Company: PETVW
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001493152-25-006783
Chunk: 9

Company: PetVivo Holdings, Inc.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 1
Chunk 9
---
 convertible debentures 
     1,325,000  
     550,000 
  
    Proceeds from issuance of notes payable 
     100,000  
     120,000 
  
    Repayments of notes payable 
     (2,404) 
     (5,073)
  
    Net Cash Provided by Financing Activities 
     4,075,696 
     5,780,057

    Net Decrease in Cash 
     (58,512) 
     (395,229)
  
    Cash at Beginning of Period 
     87,403  
     475,314 
  
    Cash at End of Period 
    $28,891  
    $80,085 

    SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: 

    Cash Paid During The Period For: 

    Interest 
    $29,461  
    $1,224 
  
    Taxes 
    $-    
    $-   
  
    SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING AND INVESTING ACTIVITIES 

    Convertible debentures and accrued interest converted to common stock 
    $301,558  
    $577,500 
  
    Stock granted for consulting services 
    $236,380  
    $280,040 
  
    (Decrease) increase to operating lease right of use asset and operating lease liability 
    $(139,198) 
    $1,081,204 

The
accompanying condensed notes are an integral part of these unaudited consolidated financial statements.

8

PetVivo
Holdings, Inc.

Condensed
Notes to Consolidated Financial Statements

December
31, 2024

(Unaudited)

NOTE
1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION

(A)
Organization and Description

The
Company is in the business of licensing and commercializing our proprietary medical devices and biomaterials for the treatment and/or
management of afflictions and diseases in animals, initially for dogs and horses. The Company began commercialization of its lead product
Spryng™ with OsteoCushion™ Technology, a veterinarian-administered, intraarticular injection for the management of lameness
and other joint afflictions such as osteoarthritis in dogs and horses in September 2021. The Company has a pipeline of additional products
for